Newsfeeds Archive - Spark Newswire

1 minute read

News

Foundation Medicine and PMV Pharma Partner to Develop Genomic Profiling for TP53 Mutation Therapy, Targets TP53 Mutation in Advanced Cancers with Investigational Therapy Rezatapopt

May 29, 7:10 AM

Foundation Medicine, Inc. and PMV Pharmaceuticals, Inc. (NASDAQ:PMVP, ", PMV Pharma", )))) today announced a partnership to develop Foundation Medicine's tissue-based comprehensive genomic profiling

PMVP

3 minute read

Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

October 13, 1:31 PM

Gainers Bio-Path Hldgs (NASDAQ:BPTH) shares rose 60.6% to $0.63 during Friday’s regular session. Bio-Path Hldgs’s stock is trading…

ATPC

4 minute read

Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

October 13, 1:14 PM

Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.

1 minute read

Precision Oncology PMV Pharmaceuticals Reveals Early Data From Cancer Study In Pretreated Patients

By Vandana Singh

October 12, 2:13 PM

PMV Pharmaceuticals Inc (NASDAQ: PMVP) announced updated Phase 1 results from its ongoing Phase 1/2 PYNNACLE trial that showed PC14586 achieved efficacy in heavily pretreated patients across multiple tumor types and was well tolerated with a

PMVP

3 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

October 12, 1:37 PM

Gainers OpGen (NASDAQ:OPGN) shares increased by 429.8% to $1.78 during Thursday’s regular session. OpGen’s stock is trading at…

ATPC

4 minute read

PMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With A TP53 Y220C Mutation

By Benzinga Newsdesk

October 12, 12:32 PM

Updated PC14586 Phase 1 data presented today as a late-breaking poster at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsConfirmed responses observed in multiple tumor types

PMVP

1 minute read

PMV Pharmaceuticals To Present Updated Phase 1 Data On PC14586 At The 2023 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics And Host A KOL Webinar

By Benzinga Newsdesk

October 11, 12:05 PM

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that it will present updated

PMVP

3 minute read

Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

September 22, 2:22 PM

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions.

AMTI

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

August 9, 5:32 PM

Gainers Vistagen Therapeutics (NASDAQ:VTGN) stock rose 22.5% to $8.62 during Wednesday’s after-market session. Trading volume for this security…

ACGN

6 minute read

Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday’s Session

By Lisa Levin

August 9, 3:17 PM

Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.

AGTI